The Diclofenac/Pridinol combination may be part of symptomatic management, applied across domains where additional symptomatic support is needed due to symptoms related to inflammatory or irritative states and symptoms of increased neurological or muscular activity. This category of medicine is associated with symptomatic relief across therapeutic domains involving pain and inflammatory or irritative states. The combination is generally applicable for use in adults experiencing symptoms associated with acute or episodic changes.

---

The product is applied across domains where additional symptomatic support is needed during acute episodes in conditions characterized by periods of heightened symptoms. This includes conditions such as severe low back pain (lumbago), sciatica, torticollis (wry neck), and painful flare-ups in conditions like osteoarthritis or certain spinal syndromes. It provides support that helps ease the overall symptom burden.

“The supportive therapeutic benefit may include assisting with maintaining functional stability and contributing to improved day-to-day comfort during episodes of heightened discomfort.”

The medication is commonly used across conditions presenting with acute episodes, particularly following musculoskeletal trauma (e.g., sprains or strains) or in active rheumatic diseases (e.g., tendonitis). It assists with maintaining functional stability and contributes to improved comfort during symptomatic periods.

Quick Fact: Relevant for Managing Painful Muscle Contracture

Diastone Flex is officially approved for use only in adults (18 years of age and older). The medicine is not approved for the pediatric population, as safety and efficacy have not been established by regulatory authorities.

---

Contraindicated Populations

Use of this medicine is strictly prohibited if you have known hypersensitivity to Diclofenac, Pridinol, Aspirin, or any other Non-Steroidal Anti-Inflammatory Drug (NSAID). Absolute contraindications also apply to patients with active gastrointestinal ulceration or bleeding, glaucoma, certain types of arrhythmia, and conditions like prostate hypertrophy or gastrointestinal obstructions due to the Pridinol component. The medicine must not be used during the first trimester of pregnancy and is avoided from 30 weeks gestation onward. It is also contraindicated for managing perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

---

Restricted and Conditional Use

Use is not recommended while breastfeeding. Patients with severe hepatic or renal impairment or severe heart failure should use this medicine only with caution and close monitoring, or may be directed to avoid it entirely, as defined by regulatory guidance. The elderly population requires special consideration due to an increased risk of serious adverse events.

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Diastone Flex (Diclofenac/Pridinol) as specified in regulatory labeling.

Contraindications and Restrictions

Category	Regulatory Statement
Formal Contraindication	Contraindicated for perioperative pain management in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Co-administration Restriction	Concurrent use with other oral NSAIDs or analgesic doses of aspirin is generally avoided due to a heightened risk of serious gastrointestinal events.

Documented Pharmacodynamic and Metabolic Interactions

Co-administration with anticoagulants and antiplatelet agents increases the documented risk of serious gastrointestinal bleeding and adverse events. The Diclofenac component may diminish the antihypertensive effect of ACE inhibitors and ARBs, and reduce the efficacy of diuretics, leading to a potential for renal function deterioration in the elderly or renally impaired. Substances classified as strong CYP inhibitors, such as Voriconazole, can formally increase the plasma concentration of the Diclofenac component. The Pridinol component may increase the severity of CNS depressant activities when co-administered with other CNS depressants. Diclofenac co-administration can also increase the serum concentration of Digoxin and Lithium. Alcohol consumption is restricted due to an increased risk of gastric ulcers.

Diastone Flex, a nonsteroidal anti-inflammatory drug, functions primarily by non-selectively inhibiting cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. It acts as a competitive inhibitor, occupying the active site and preventing the binding of the substrate arachidonic acid. This molecular blockade halts the committed step in the synthesis of prostanoids.

Molecular and Intracellular Pathways

Intracellularly, the inhibition of COX enzymes results in a dose-dependent reduction of prostaglandin E2 ( PGE2), prostacyclin ( PGI2), and thromboxane ( TXA2) synthesis in various tissues. PGE2 and PGI2 are eicosanoid lipid mediators derived from the arachidonic acid cascade. The subsequent downstream cascade includes reduced activation of peripheral afferent nerve fibers by prostaglandins and modulation of the local inflammatory cellular environment. The drug accumulates preferentially in inflamed synovial fluid, sustaining its action at the peripheral site of the targeted tissue.

System-Level Physiological Consequences

This molecular and cellular modulation culminates in a systemic alteration of eicosanoid-mediated signaling. The resulting physiological consequences are a reduction in the biochemical processes that mediate local tissue responses, particularly those involving vasodilation, leukocyte recruitment, and local nerve sensitization, leading to a modified homeostatic set-point for these processes.

How to Use Diastone Flex: Official Administration Guidelines

Official instructions for the use of this fixed-dose combination product detail administration via two approved routes and emphasize conservative dosing principles common to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

---

Administration Scope	Official Instruction or Principle
Route of Administration	The medicine is approved for oral administration (tablet) and intramuscular (IM) injection (solution).
Dosing Schedule	Use the lowest effective dose for the shortest duration necessary for treatment goals.
Frequency and Timing	Oral tablets are typically administered in divided daily doses. The injectable form is for intermittent use only, generally not exceeding two days.
Timing in Relation to Meals	Oral tablets should be taken with sufficient fluid. Administration may be adjusted to be before meals for faster onset; however, patients with hypotension should take them after meals.
Preparation Requirements	Oral tablets must be swallowed whole (not chewed). The injection requires a deep intragluteal administration by a healthcare professional.
Age-Group Rules	The lowest effective dosage is advised for older adults and for patients with known hepatic or renal impairment.
Missed-Dose Rule	If a dose is missed, take the next dose at the regularly scheduled time; do not take a double dose to compensate.

---

Resulting Procedural Structure

The established usage protocol mandates a brief course of treatment, aligning with the shortest duration principle required for NSAIDs. The combination of oral and parenteral routes allows for a structured approach: the injection is reserved for acute, severe episodes, while the tablet form supports the continuation of the prescribed divided daily doses. All use must remain below the authorized maximum daily dose for the fixed combination, and dosing for vulnerable populations must begin conservatively.

Research evidence / Overview of studies for Diastone Flex

---

Evidence for use in Acute Musculoskeletal Pain

This section summarizes the available research, including the role of pilot studies and open-label trials, in observing the fixed-dose combination for conditions such as severe lumbago (low back pain) and cervical-brachialgia (pain extending from the neck to the arm), detailing the populations and outcomes examined.

Research was conducted on the fixed-dose combination of Diclofenac and Pridinol in adult patients with acute musculoskeletal discomfort, particularly in conditions characterized by painful muscle contracture. These studies were designed to monitor outcomes related to changes in physical symptoms and measured how symptoms evolved in the observed populations during the study period.

Data show patterns related to pain intensity and daily functioning over defined time intervals. However, the high-level evidence, such as large randomized controlled trials (RCTs), specific to the fixed-dose combination is limited for these particular conditions. The reported outcomes were short-term, generally covering observation periods of only one to three weeks.

---

Evidence for use in Painful Muscle Spasm and Contracture

This part details the research landscape for addressing muscular rigidity, including the findings from meta-analyses of the Pridinol component and the focus of studies on physical symptoms like stiffness and restricted movement.

Pridinol, the muscle relaxant component, was evaluated in research exploring symptoms related to muscle stiffness. Studies examined this component in adult populations with acute and subacute muscular pain. Evidence describing the muscle relaxant component includes meta-analyses, which pool data from multiple studies. These research reviews describe patterns observed in physical outcomes like stiffness and tenderness, though the synthesis is based on a modest number of suitable placebo-controlled trials.

It is important to note that the existing evidence provides limited insight into the exact contribution of the muscle relaxant when used within the fixed-dose combination versus when used alone. Furthermore, the synthesis for the muscle relaxant component contributes to the research uncertainty.

---

What Remains Uncertain in the Research Landscape

This concluding summary synthesizes the main limitations of the current evidence. The overall evidence for the fixed-dose combination, particularly in comparison to the individual components, is affected by the fact that sample sizes were modest in key studies. Comparative evidence is lacking to fully characterize the specific therapeutic role of the combination product. Research is ongoing, but certainty remains low in certain areas.

Key Studies & References Efficacy and safety/tolerability of pridinol: a meta-analysis of double-blind, randomized, placebo-controlled trials in adult patients with muscle pain

Common questions about Diastone Flex (FAQ)

---

Q: Can Diastone Flex be taken by people with high blood pressure or heart conditions?

Regulatory documents indicate that patients with risk factors like high blood pressure (hypertension) should be treated with careful medical consideration. Official product information states the medicine is generally contraindicated, meaning its use is avoided or not recommended, for patients with established severe heart failure or those recovering from certain heart surgeries, such as coronary artery bypass graft (CABG) surgery.

Q: Is it safe to use other pain relievers (like Tylenol or ibuprofen) while taking Diastone Flex?

Official labeling advises against concurrent use with other oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, due to a heightened risk of serious stomach or intestinal bleeding. Regulatory warnings about acetaminophen (Tylenol) caution against exceeding the maximum daily dose, as combining it with NSAIDs may increase the overall risk of liver toxicity.

Q: How is Diastone Flex different from its predecessor or similar medicines in the same class?

Official regulatory descriptions define Diastone Flex as a fixed-dose combination product. This means it contains two active ingredients: an NSAID (Diclofenac) and a central muscle relaxant (Pridinol). This dual-component approach is designed to concurrently address both pain/inflammation and muscle spasm in a single medicine.

Q: Are there any known drug-food interactions for Diastone Flex, besides alcohol?

Official data for the NSAID component indicates that food generally has no significant effect on the extent of how the drug is absorbed into the body. Official administration instructions may address the timing of administration in relation to meals, but the presence of food does not typically change the overall amount of medication that enters the bloodstream.

Q: Are there any specific symptoms that would require me to stop taking Diastone Flex immediately?

Regulatory warnings state that emergency medical help should be sought immediately if signs of a severe allergic reaction (e.g., swelling of the face, difficulty breathing) or symptoms of a serious gastrointestinal or cardiovascular event occur. This includes sudden chest pain, weakness on one side of the body, black/tarry stools, or persistent, unexplained flu-like symptoms.

Q: Why might Diastone Flex be prescribed over other older medicines for the same condition?

Regulatory descriptions confirm the medicine's official purpose is to provide integrated management of pain, inflammation, and muscle spasm. This is achieved through the combined action of its two distinct active ingredients (NSAID and muscle relaxant) in a single formulation for conditions characterized by painful muscle contractures.

Q: Is Diastone Flex known to cause any skin reactions or rashes?

Official documents list a general rash and itching skin as common or occasional adverse effects reported during treatment. These are typically mild and distinct from the rare, severe skin reactions that would constitute a medical emergency.

Q: What is the scientific reasoning behind avoiding Diastone Flex in certain disease states?

The contraindications are based on known pharmacological risks associated with the two components. The NSAID component is avoided in conditions like severe heart failure due to cardiovascular risks, while the muscle relaxant component is avoided in conditions like glaucoma due to potential effects on eye pressure.

Q: Does Diastone Flex work the same way as common over-the-counter pain relievers?

The Diclofenac component belongs to the same class as many over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) and works similarly by inhibiting certain enzymes in the body. However, this product is a combination medicine that also includes a central muscle relaxant, which has a distinct mechanism of action to ease muscle stiffness.

Q: Why is Diastone Flex available by prescription only?

The components are classified as requiring medical supervision due to the potential for serious, dose- and duration-dependent risks associated with the NSAID component (e.g., cardiovascular and gastrointestinal events). The central nervous system effects of the muscle relaxant also contribute to the necessity for medical guidance.

Q: Does Diastone Flex affect blood pressure or cause fluid retention?

Regulatory documents list hypertension (high blood pressure) and conditions often related to fluid retention, such as congestive heart failure and edema (swelling), as occasional adverse experiences reported during treatment. These effects are associated with the NSAID component of the medicine.

Q: Will taking Diastone Flex affect the effectiveness of my birth control pills?

Authoritative sources generally state that the NSAID component is not known to reduce the effectiveness of hormonal contraceptives. However, the muscle relaxant component may cause side effects like vomiting or severe diarrhea, and if this occurs shortly after taking an oral contraceptive, its effectiveness could potentially be compromised.

Q: What should I do if I notice a change in how my other medications are working after starting Diastone Flex?

Regulatory labeling indicates that this medicine may interact with certain other drugs, which can diminish the effect of some medications (like blood pressure drugs) or increase the concentration of others (like Digoxin). These interactions may necessitate close monitoring by a healthcare professional.

Q: Can Diastone Flex affect my ability to drive or operate machinery?

Regulatory warnings caution that due to potential side effects such as dizziness or drowsiness, a caution against driving or operating machinery is included if attention, judgment, or physical ability is impaired. These central nervous system effects are often associated with the muscle relaxant component.

Q: How do I know if Diastone Flex is actually working for my condition?

Clinical trials for the medication measured outcomes related to changes in physical symptoms. This includes monitoring for improvements in pain intensity, reduction in muscle stiffness, and overall changes in daily functioning during the prescribed treatment period.

Q: What are the official recommendations regarding the use of Diastone Flex with narcotics or opioid pain relievers?

Regulatory warnings advise caution when the muscle relaxant component is co-administered with other central nervous system (CNS) depressants, which may include narcotics. This is due to the potential for increased severity of CNS effects, such as enhanced drowsiness or dizziness.

Q: Are there any restrictions on physical activities or sun exposure while taking Diastone Flex?

Regulatory warnings advise that the NSAID component may increase the sensitivity of the skin to sunlight. Due to this, caution is advised when exposed to bright sun and using protective measures like clothing and high-factor sun cream.

Q: Does Diastone Flex cause any change in appetite or weight?

Regulatory documents list weight changes and loss of appetite as occasional adverse experiences reported during treatment. Reporting these effects to a healthcare professional is standard practice if they become concerning.

How to Store and Dispose of Diastone Flex?

The official guidelines for storing and disposing of this combination medicine are derived from regulatory documents to maintain product integrity and environmental safety.

---

Mandatory Storage Requirements

Diastone Flex must be stored at controlled room temperature, typically below 25 C or 30 C, as specified on the package label. It is critical to protect the medicine from light and moisture and to not freeze the product. To ensure product integrity, the tablets or solution must remain in the original container until use.

---

Official Disposal Rules

For safety, the product must always be stored out of the sight and reach of children. When disposal is necessary (for expired or unused medicine), it must not be thrown away in household trash or poured into wastewater (sinks or toilets). Instead, disposal must strictly follow local pharmaceutical waste regulations, usually through an authorized medicine take-back program or collection point.